📣 VC round data is live. Check it out!

Merit Medical Systems Valuation Multiples

Discover Merit Medical Systems' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Envista Holdings, iRhythm Holdings, Medacta Group, Minimed Group and more.

Merit Medical Systems Overview

About Merit Medical Systems

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.


Founded

1987

HQ

United States

Employees

7.5K

Website

merit.com

Financials (LTM)

Revenue: $2B
EBITDA: $388M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Merit Medical Systems Financials

Merit Medical Systems reported last 12-month revenue of $2B and EBITDA of $388M.

In the same LTM period, Merit Medical Systems generated $813M in gross profit, $388M in EBITDA, and $239M in net income.

Revenue (LTM)


Merit Medical Systems P&L

In the most recent fiscal year, Merit Medical Systems reported revenue of $2B and EBITDA of $380M.

Merit Medical Systems is profitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 25%, and net margin of 15%.

See analyst estimates for Merit Medical Systems
LTMLast FY202320242025202620272028
Revenue$2B$2B$1B$1B$2B
Gross Profit$813M$738M$584M$643M$738M
Gross Margin52%49%46%47%49%
EBITDA$388M$380M$229M$296M$332M
EBITDA Margin25%25%18%22%22%
EBIT Margin20%20%10%12%12%
Net Profit$239M$231M$94M$120M$128M
Net Margin15%15%8%9%8%
Net Debt-$288M---

Financial data powered by Morningstar, Inc.

Merit Medical Systems Stock Performance

Merit Medical Systems has current market cap of $4B, and enterprise value of $4B.

Market Cap Evolution


Merit Medical Systems' stock price is $60.89.

Merit Medical Systems share price decreased by 3.4% in the last 30 days, and by 34.9% in the last year.

Merit Medical Systems has an EPS (earnings per share) of $3.88.

See more trading valuation data for Merit Medical Systems
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$4B-1.9%-3.4%-11.7%-34.9%$3.88

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Merit Medical Systems Valuation Multiples

Merit Medical Systems trades at 2.5x EV/Revenue multiple, and 10.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Merit Medical Systems

EV / Revenue (LTM)


Merit Medical Systems Financial Valuation Multiples

As of June 3, 2026, Merit Medical Systems has market cap of $4B and EV of $4B.

Merit Medical Systems has a P/E ratio of 15.2x.

LTMLast FY202320242025202620272028
EV/Revenue2.5x2.6x3.2x2.9x2.6x
EV/EBITDA10.2x10.4x17.3x13.4x11.9x
EV/EBIT12.4x12.9x31.1x25.4x21.4x
EV/Gross Profit4.9x5.4x6.8x6.2x5.4x
P/E15.2x15.7x38.5x30.2x28.3x
EV/FCF18.0x18.4x36.6x21.7x18.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Merit Medical Systems Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Merit Medical Systems Margins & Growth Rates

Merit Medical Systems grew revenue by 7% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, Merit Medical Systems reported gross margin of 49%, EBITDA margin of 25%, and net margin of 15%.

See estimated margins and future growth rates for Merit Medical Systems

Merit Medical Systems Margins

Last FY202420252026202720282029
Gross Margin49%47%49%52%
EBITDA Margin25%22%22%25%
EBIT Margin20%12%12%21%
Net Margin15%9%8%15%
FCF Margin14%13%14%14%

Merit Medical Systems Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%8%12%7%
Gross Profit Growth15%10%15%15%
EBITDA Growth5%29%12%20%
EBIT Growth9%22%19%81%
Net Profit Growth8%27%7%95%
FCF Growth5%69%16%7%

Data powered by FactSet, Inc. and Morningstar, Inc.

Merit Medical Systems Operational KPIs

Merit Medical Systems' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Merit Medical Systems' Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Merit Medical Systems' Rule of X is 42% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Merit Medical Systems
LTMLast FY202320242025202620272028
Rule of 4031%32%---
Bessemer Rule of X41%42%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue6%6%7%6%6%
Opex to Revenue-36%36%36%36%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Merit Medical Systems Competitors

Merit Medical Systems competitors include Envista Holdings, iRhythm Holdings, Medacta Group, Minimed Group, Lepu Medical Technology, Amplifon, Ottobock, Jiangsu Yuyue Medical, ICU Medical and LivaNova.

Most Merit Medical Systems public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Envista Holdings1.6x1.5x11.4x11.0x
iRhythm Holdings4.9x4.5x52.9x42.3x
Medacta Group4.7x4.5x16.3x16.0x
Minimed Group1.3x1.1x32.3x10.3x
Lepu Medical Technology3.8x3.7x12.2x12.2x
Amplifon1.8x1.8x8.2x8.0x
Ottobock2.8x2.7x15.2x10.6x
Jiangsu Yuyue Medical3.3x3.2x13.3x16.2x

This data is available for Pro users. Sign up to see all Merit Medical Systems competitors and their valuation data.

Start Free Trial

Acquisitions by Merit Medical Systems

Merit Medical Systems has acquired 8 companies to date.

Last acquisition by Merit Medical Systems was on March 31st 2026. Merit Medical Systems acquired View Point Medical for $140M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Merit Medical Systems

View Point Medical
Biolife
Cook Medical (Lead Management Portfolio unit)
EndoGastric Solutions
Description
View Point Medical manufactures implantable tissue markers for cancer lesion localization, centered on the SignalMark platform compatible with ultrasound, X-ray, MRI, and CT imaging. Designed for breast, prostate, and other applications, the markers provide durable visibility during surgery and follow-up procedures. The Tel Aviv-based company advances minimally invasive diagnostics across oncology centers.
Biolife is a Louisville-based medical devices firm that manufactures first aid kits, burn dressings, and wound care products. Their portfolio includes BioLifeCleanse antimicrobial washes and HydroGel burn gels used by emergency services, schools, and industrial sites. Distributed nationwide through partnerships with safety equipment suppliers, the company emphasizes rapid-response applications for trauma and infection control.
-
EndoGastric Solutions is a medical technology firm commercializing incisionless therapies for gastroesophageal reflux disease. Its EsophyX device performs transoral incisionless fundoplication in outpatient settings, treating GERD patients in clinics throughout the United States and Europe.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
San Diego, CA
Sarasota, FL
-
San Francisco, CA
Deal Date31 Mar 202620 May 202517 Sep 20241 Jan 2024
Valuation$140M$120M$210M$105M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Merit Medical Systems acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Merit Medical Systems

When was Merit Medical Systems founded?Merit Medical Systems was founded in 1987.
Where is Merit Medical Systems headquartered?Merit Medical Systems is headquartered in United States.
How many employees does Merit Medical Systems have?As of today, Merit Medical Systems has over 7K employees.
Who is the CEO of Merit Medical Systems?Merit Medical Systems' CEO is Martha Goldberg Aronson.
Is Merit Medical Systems publicly listed?Yes, Merit Medical Systems is a public company listed on Nasdaq.
What is the stock symbol of Merit Medical Systems?Merit Medical Systems trades under MMSI ticker.
When did Merit Medical Systems go public?Merit Medical Systems went public in 1990.
Who are competitors of Merit Medical Systems?Merit Medical Systems main competitors include Envista Holdings, iRhythm Holdings, Medacta Group, Minimed Group, Lepu Medical Technology, Amplifon, Ottobock, Jiangsu Yuyue Medical, ICU Medical, LivaNova.
What is the current market cap of Merit Medical Systems?Merit Medical Systems' current market cap is $4B.
What is the current revenue of Merit Medical Systems?Merit Medical Systems' last 12 months revenue is $2B.
What is the current revenue growth of Merit Medical Systems?Merit Medical Systems revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of Merit Medical Systems?Current revenue multiple of Merit Medical Systems is 2.5x.
What is the current EBITDA of Merit Medical Systems?Merit Medical Systems' last 12 months EBITDA is $388M.
What is Merit Medical Systems' EBITDA margin?Merit Medical Systems' last 12 months EBITDA margin is 25%.
What is the current EV/EBITDA multiple of Merit Medical Systems?Current EBITDA multiple of Merit Medical Systems is 10.2x.
What is the current FCF of Merit Medical Systems?Merit Medical Systems' last 12 months FCF is $221M.
What is Merit Medical Systems' FCF margin?Merit Medical Systems' last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Merit Medical Systems?Current FCF multiple of Merit Medical Systems is 18.0x.
How many companies Merit Medical Systems has acquired to date?As of June 2026, Merit Medical Systems has acquired 8 companies.
What was the largest acquisition by Merit Medical Systems?$210M acquisition of Cook Medical (Lead Management Portfolio unit) on 17th September 2024 was the largest M&A Merit Medical Systems has done to date.
What companies Merit Medical Systems acquired?Merit Medical Systems acquired Cook Medical (Lead Management Portfolio unit), View Point Medical, Cianna Medical, Biolife, EndoGastric Solutions, DFine, Vascular Insights, and BrightWater Medical.
In how many companies Merit Medical Systems has invested to date?Merit Medical Systems hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Merit Medical Systems

Lists including Merit Medical Systems

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial